Carregant...
Utilization of individualized prostate cancer and genomic biomarkers for the practicing urologist
Prostate cancer encompasses a complex heterogeneous disease spectrum. Physicians and patients are faced with the ambiguity of who should be screened, biopsied, rebiopsied, treated, or provided with adjuvant therapy. Personalized outcomes and treatments are especially important given the varied natur...
Guardat en:
| Publicat a: | Rev Urol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MedReviews, LLC
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5610359/ https://ncbi.nlm.nih.gov/pubmed/28959146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0730 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|